$1.28
-0.15-10.49%
At Close: -
$1.33
0.053.91%
After Hours: 5:12 PM EDT
15 minutes delayed
Immuneering
IMRXNASDAQ
Immuneering (NASDAQ:IMRX) Stock Quotes, Forecast and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open | $1.44 |
| Close | $1.28 |
| Volume / Avg. | 2.51M / 368.34K |
| Day Range | 1.28 - 1.44 |
| 52 Wk Range | 1.30 - 11.06 |
| Market Cap | $39.44M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 16.71% |
| Days to Cover | 13.92 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Immuneering Corp
Sector
Health Care
Industry
Biotechnology
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Who are Immuneering (IMRX) competitors?
Other companies in Immuneering’s space includes: Kezar Life Sciences (NASDAQ:KZR), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and BioLine Rx (NASDAQ:BLRX).
What is the target price for Immuneering (IMRX) stock?
There is no analysis for Immuneering.
What is the forecast for Immuneering (IMRX) stock?
Immuneering has a consensus price target of $13.77.
Current stock price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $1.33 last updated June 28, 2024 at 5:12 PM EDT.
Does Immuneering (IMRX) pay a dividend?
There are no upcoming dividends for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.